These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25769615)

  • 1. Effect of age and sex on the pharmacokinetics and safety of avibactam in healthy volunteers.
    Tarral A; Merdjan H
    Clin Ther; 2015 Apr; 37(4):877-86. PubMed ID: 25769615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteers.
    Tominaga N; Edeki T; Li J; Learoyd M; Bouw MR; Das S
    J Infect Chemother; 2015 Aug; 21(8):551-8. PubMed ID: 26076867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients.
    Bradley JS; Armstrong J; Arrieta A; Bishai R; Das S; Delair S; Edeki T; Holmes WC; Li J; Moffett KS; Mukundan D; Perez N; Romero JR; Speicher D; Sullivan JE; Zhou D
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6252-9. PubMed ID: 27503642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment.
    Merdjan H; Tarral A; Das S; Li J
    J Clin Pharmacol; 2017 Feb; 57(2):211-218. PubMed ID: 27402250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and pharmacokinetics of single and multiple ascending doses of avibactam alone and in combination with ceftazidime in healthy male volunteers: results of two randomized, placebo-controlled studies.
    Merdjan H; Rangaraju M; Tarral A
    Clin Drug Investig; 2015 May; 35(5):307-17. PubMed ID: 25813217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Ceftazidime-Avibactam in Healthy Chinese Subjects.
    Li J; Learoyd M; Qiu F; Zhu L; Edeki T
    Clin Drug Investig; 2016 Feb; 36(2):119-26. PubMed ID: 26649741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects.
    Riccobene TA; Su SF; Rank D
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1496-504. PubMed ID: 23295928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
    Qin X; Tran BG; Kim MJ; Wang L; Nguyen DA; Chen Q; Song J; Laud PJ; Stone GG; Chow JW
    Int J Antimicrob Agents; 2017 May; 49(5):579-588. PubMed ID: 28363526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P
    Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.
    MacGowan A; Tomaselli S; Noel A; Bowker K
    J Antimicrob Chemother; 2017 Mar; 72(3):762-769. PubMed ID: 28039276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens.
    Nicolau DP; Siew L; Armstrong J; Li J; Edeki T; Learoyd M; Das S
    J Antimicrob Chemother; 2015 Oct; 70(10):2862-9. PubMed ID: 26133566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam.
    Das S; Armstrong J; Mathews D; Li J; Edeki T
    J Clin Pharmacol; 2014 Mar; 54(3):331-40. PubMed ID: 24150927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avibactam Pharmacokinetic/Pharmacodynamic Targets.
    Nichols WW; Newell P; Critchley IA; Riccobene T; Das S
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers.
    Mallalieu NL; Winter E; Fettner S; Patel K; Zwanziger E; Attley G; Rodriguez I; Kano A; Salama SM; Bentley D; Geretti AM
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32041717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults.
    Lodise TP; O'Donnell JN; Balevic S; Liu X; Gu K; George J; Raja S; Guptill JT; Zaharoff S; Schwager N; Fowler VG; Wall A; Wiegand K; Chambers HF;
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0093622. PubMed ID: 36394326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment.
    Preston RA; Mamikonyan G; DeGraff S; Chiou J; Kemper CJ; Xu A; Mastim M; Yeole R; Chavan R; Patel A; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
    Singh R; Kim A; Tanudra MA; Harris JJ; McLaughlin RE; Patey S; O'Donnell JP; Bradford PA; Eakin AE
    J Antimicrob Chemother; 2015 Sep; 70(9):2618-26. PubMed ID: 26024868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.